Alector

ALEC · NASDAQ

$1.97+$0.02 (+1.03%)TodayMarket closed ·
Prev close $1.95

Latest news

  • Press releaseGlobe Newswire

    Biotech Brainiacs and Breakthroughs

  • Press releaseGlobe Newswire

    Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases

  • NewsTim Melvin

    Alpha Buying: Follow the Money From NVIDIA and Merck

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • NewsVandana Singh

    GSK Adds Positive Phase 3 Lung Cancer Data, Ends Alector Partnership

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Monday's Pre-Market Session

  • News

    Alector Q4 Earnings Assessment

  • Press releasePRNewswire

    INVESTOR ALERT: Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint

  • Press releaseGlobe Newswire

    ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

  • Press releaseGlobe Newswire

    ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

  • Press releaseBusiness Wire

    ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

  • Press releaseGlobe Newswire

    Alector Reports Third Quarter 2025 Financial Results and Provides Business Update

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alector, Inc. - ALEC

  • NewsAvi Kapoor

    Crude Oil Gains Over 1%; AT&T Shares Slide After Q3 Results

  • NewsVandana Singh

    Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce

  • NewsAvi Kapoor

    Dow Falls 100 Points; Netflix Shares Tumble On Downbeat Earnings

  • NewsAvi Kapoor

    Netflix Posts Downbeat Earnings, Joins Aveanna Healthcare, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Why Intuitive Surgical Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    AT&T, Netflix And 3 Stocks To Watch Heading Into Wednesday

  • Press releaseGlobe Newswire

    Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update

  • NewsVishaal Sanjay

    Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • Press releaseGlobe Newswire

    Alector Reports Second Quarter 2025 Financial Results and Provides Business Update

  • Press releaseGlobe Newswire

    Alector Provides Executive Leadership Update

  • Press releaseGlobe Newswire

    Alector Reports First Quarter 2025 Financial Results and Provides Business Update

  • Press releaseGlobe Newswire

    Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer's Disease

  • Press releaseGlobe Newswire

    Alector Provides Executive Leadership Update

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • NewsAvi Kapoor

    Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Views

  • NewsAvi Kapoor

    Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results

  • NewsAvi Kapoor

    US Stocks Mixed; Best Buy Posts Downbeat Earnings

  • NewsAvi Kapoor

    Leslie's Posts Weak Results, Joins Zoom Video And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

  • News

    Market-Moving News for November 26th

  • NewsAvi Kapoor

    Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.